Skip to main content

View full-text article in PMC

. 2010 May 31;18(3):153–159. doi: 10.1016/j.jsps.2010.05.001

Table 7.

Solution stability study.

Time of analysis	Salmeterol xinafoate		Fluticasone propionate^⁎⁎
	Average peak area (n = 6) ± SD	CV^a	Average peak area (n = 6) ± SD	CV^a
20 min	3828.67 ± 114.7	2.03	5615.95 ± 60.3	2.17
3 h	3795.11 ± 52.0	2.87	5742.12 ± 101.9	0.99
8 h	3830.88 ± 52.2	0.95	5524.711 ± 36.2	0.95
24 h	3807.87 ± 35.84	1.01	5498.48 ± 38.7	0.65
4 days	3543.85 ± 109.3	1.27	5266.6 ± 48.5	1.90
12 days	2974.7 ± 67.3	1.51	5263.12 ± 57.9	1.20

^a

CV: coefficient of variation.

^⁎⁎

Multi dose analysis.